GlassScriptPhysician profile
John Kyle Dorman
NPI 1215030333
$12,058.40
in general payments reported to CMS, 2019-2025
30 companies · $1,166 in 2025
The $1,166 reported for 2025 was more than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,155 · 2020: $1,703 · 2021: $6,166 · 2022: $761 · 2023: $868 · 2024: $239 · 2025: $1,166.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,583 · Travel and Lodging: $690.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,582.75 |
| Travel and Lodging | $690.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alphatec Spine, INC | $4,368.20 | 2019-2025 | Biologics |
| Medtronic, INC. | $1,636.17 | 2021-2025 | Mazor X System |
| Medtronic USA, INC. | $955.88 | 2020 | |
| Rattan and Associates | $670.11 | 2025 | |
| Zimmer Biomet Holdings, INC. | $658.27 | 2019-2021 | |
| Spinal Simplicity, LLC | $551.98 | 2021 | |
| Orthofix Medical, INC. | $440.92 | 2019-2024 | Cervical-Stim |
| Zavation Medical Products, LLC | $297.25 | 2023 | |
| Arthrex, INC. | $285.05 | 2025 | |
| Nuvasive, INC. | $260.51 | 2021 | |
| Cerapedics INC. | $257.00 | 2021-2022 | |
| Circinus Medical Technology LLC | $236.00 | 2023 | Bolt Navigation Unit |
| Adcura, INC. | $161.26 | 2023 | |
| Abbott Laboratories | $150.57 | 2021 | |
| Si-Bone, INC. | $146.64 | 2021 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aesculap, INC. | $133.03 | 2019-2020 | |
| Augmedics INC. | $115.15 | 2021-2023 | Xvision |
| Aesculap Implant Systems, LLC | $104.15 | 2019 | |
| Potrero Medical, INC. | $101.52 | 2022 | |
| Kls-Martin L.P. | $99.50 | 2021 | |
| Irras USA, INC. | $91.22 | 2021 | |
| Stryker Corporation | $82.61 | 2019-2022 | |
| Novo Nordisk INC | $67.54 | 2019 | |
| Merck Sharp & Dohme LLC | $44.42 | 2023-2025 | Bridion |
| Camber Spine Technologies LLC | $43.39 | 2021 | |
| Baxter Healthcare | $29.98 | 2021 | |
| Innovation Technologies INC | $24.81 | 2023 | Irrisept |
| Boston Scientific Corporation | $16.58 | 2023 | Watchman Flx |
| Integra Lifesciences Corporation | $14.40 | 2023 | Codman Certas, Cusa Clarity, Codman Hakim |
| Ethicon US, LLC | $14.29 | 2025 | Echelon; Endopath, Vistaseal, Linx Reflux Management System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$33,925,545.20 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Dorman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.